The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

被引：204
|
作者：
Nichol, KL [1 ]
机构：
[1] Univ Minnesota, VA Med Ctr, Minneapolis, MN 55417 USA
来源：
VACCINE | 2003年 / 21卷 / 16期
关键词：
efficacy; influenza; vaccination; cost effectiveness;
D O I：
10.1016/S0264-410X(03)00070-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Influenza is a major cause of morbidity and mortality worldwide. Currently available inactivated influenza virus vaccines are safe and effective in preventing influenza. Substantial health benefits are seen across all age and risk groups. Studies assessing the economic benefits of vaccination suggest that vaccination is highly cost effective and in many cases cost saving among the elderly. Influenza vaccination has also been associated with significant economic benefits in younger adults and children. Additional health economic studies from developing countries and from tropical/subtropical regions will be vitally important for better understanding of the global burden of influenza and potential benefits of vaccination. Published by Elsevier Science Ltd.
引用
收藏
页码：1769 / 1775
页数：7
相关论文
共 50 条
  • [1] Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
    Bianculli, Pablo Manuel
    Bellier, Lucile
    Mangado, Ignacio Olivera
    Perez, Carlos Grau
    Mieres, Gustavo
    Lazarov, Luis
    Petitjean, Audrey
    Dibarboure, Hugo
    Lopez, Juan Guillermo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [2] Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
    Dominic Thorrington
    Edwin van Leeuwen
    Mary Ramsay
    Richard Pebody
    Marc Baguelin
    BMC Medicine, 15
  • [3] Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
    Thorrington, Dominic
    van Leeuwen, Edwin
    Ramsay, Mary
    Pebody, Richard
    Baguelin, Marc
    BMC MEDICINE, 2017, 15
  • [4] Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
    Thommes, Edward W.
    Kruse, Morgan
    Kohli, Michele
    Sharma, Rohita
    Noorduyn, Stephen G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (04) : 867 - 876
  • [5] Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults
    Loong, Desmond
    Pham, Ba'
    Amiri, Mohammadreza
    Saunders, Hailey
    Mishra, Sujata
    Radhakrishnan, Amruta
    Rodrigues, Myanca
    Yeung, Man Wah
    Mueller, Matthew P.
    Straus, Sharon E.
    Tricco, Andrea C.
    Isaranuwatchai, Wanrudee
    VALUE IN HEALTH, 2022, 25 (08) : 1439 - 1458
  • [6] Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
    Mattock, Richard
    Gibbons, Ilana
    Moss, Joe
    Mealing, Stuart
    Largeron, Nathalie
    Carroll, Stuart
    Alvarez, Fabian P.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1261 - 1271
  • [7] Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
    de Boer, Pieter T.
    Nagy, Lisa
    Dolk, Franklin C. K.
    Wilschut, Jan C.
    Pitman, Richard
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 19 - 31
  • [8] Current rotavirus vaccines. Efficacy and cost-effectiveness
    Forster, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (09) : 831 - +
  • [9] Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
    Clements, Karen M.
    Meier, Genevieve
    McGarry, Lisa J.
    Pruttivarasin, Narin
    Misurski, Derek A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1171 - 1180
  • [10] Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
    Ruiz-Aragon, Jesus
    Marquez-Pelaez, Sergio
    Gani, Ray
    Alvarez, Piedad
    Guerrero-Luduena, Richard
    VACCINES, 2022, 10 (02)
12345